4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-22-059566
Options or other derivatives
- Chief Executive Officer acquired 925,069 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hansen Carl L. G. Chief Executive Officer | 2022-12-01 | Grant or award · Share Options (right to buy) | +925,069 | 6,613,691 | D | ||
Loading xslF345X03/doc4.xml…